Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant

Fosaprepitant is a prodrug of aprepitant, a neurokinin(1) (NK(1)) receptor antagonist used in prophylactic antiemetic regimens used prior to cytotoxic chemotherapy. Fosaprepitant is being developed to provide a parenterally administered alternative to the orally administered aprepitant. Fosaprepitan...

Descripción completa

Detalles Bibliográficos
Autor principal: Olver, Ian N
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504061/
https://www.ncbi.nlm.nih.gov/pubmed/18728837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504061/
https://www.ncbi.nlm.nih.gov/pubmed/18728837

Ejemplares similares